Cobalt Dr MRI Surescan
Device Implantable Cardioverter Defibrillators (ICDs)
PDI 00763000178390
General payments
$1,224,086
Research payments
$13,138,605
Through program year 2025, $1,224,086 in general payments and $13,138,605 in research payments were reported against Cobalt Dr MRI Surescan (Implantable Cardioverter Defibrillators (ICDs)).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $246,510 | 4,874 |
| 2024 | General | $357,108 | 7,384 |
| 2024 | Research | $4,760,016 | 1,583 |
| 2023 | General | $315,630 | 6,482 |
| 2023 | Research | $3,867,352 | 1,341 |
| 2022 | General | $254,839 | 5,243 |
| 2022 | Research | $4,511,236 | 1,763 |
| 2021 | General | $50,000 | 4 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 59 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
23,987 general · 4,687 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.